Phase II multi-centre, non randomized, open label study of nivolumab in combination with ipilimumab as first line in adults patients with metastatic uveal melanoma. GEM 14-02
| Autor: | R. Lopez Castro, A.J. Rullan Iriarte, D. Rodriguez Abreu, Salvador Martín-Algarra, E. Espinosa, A. Lorenzo, J.M. Piulats, T. Curiel, P. Luna, L. de la Cruz Merino, Alfonso Berrocal |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Oncology medicine.medical_specialty business.industry Melanoma First line Ipilimumab Hematology medicine.disease 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Open label study 030220 oncology & carcinogenesis Internal medicine medicine Nivolumab Multi centre business medicine.drug |
| Zdroj: | Annals of Oncology. 27:vi377 |
| ISSN: | 0923-7534 |
| DOI: | 10.1093/annonc/mdw378.54 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|